Galderma Group AG

Galderma Group AG is a global pure-play dermatology company focused on delivering science-based solutions for skin health. The company operates across three main segments: injectable aesthetics, dermatological skincare, and therapeutic dermatology, offering a diversified range of products that address both medical and consumer needs. Notable brands within its portfolio include Restylane, Dysport/Azzalure, Sculptra, Cetaphil, and Alastin, targeting concerns from aging skin to chronic dermatological conditions. With over four decades of heritage and innovation in dermatology, Galderma collaborates closely with healthcare professionals to ensure effective outcomes for patients and consumers. The company leverages advanced research and clinical expertise, operating manufacturing sites and serving markets in more than 90 countries worldwide. Headquartered in Switzerland, Galderma is strategically positioned in resilient, high-growth sectors of the skin health industry, maintaining a significant footprint in both prescription and over-the-counter product markets. This specialized focus has solidified its status as a leading entity dedicated exclusively to dermatological care and advancement.